Related Experiment Video
Updated: Sep 26, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
[Clinical presentation and management of the severe acute respiratory syndrome (SARS)]
V Rickerts1, T Wolf, C Rottmann
1Medizinische Klinik III/Infektiologie, Universitätsklinik Frankfurt.
Background And Objective:
In February 2003, a newly emerged infectious disease was described, the etiology of which was initially unknown. It is referred to under the term SARS. In the beginning, it spread in some regions South-East Asia. Import infections appeared in many other parts of the world. Based on the first cases in Germany, this report illustrates the clinical appearance, the diagnostic results and the management of this new disease.
Patients And Methods:
We analysed the data of two patients with SARS and one suspected patient. The results of radiological, laboratory, microbiological and physical examinations were abstracted and compared with the data obtained in other regions.
Results:
Two of the three patients under our care developed SARS disease. This is characterised by fever of sudden onset lasting for more than 5 days, rapidly changing consolidations in chest x-ray not affected by antimicrobial therapy, leuko-, lympho- as well as thrombopenia with a compromised pulmonary function later in the course. Close contacts with SARS patients does not regularly result in full development of the disease. Secretion of a coronavirus could be detected in respiratory samples during the febrile phase and in feces for a longer time. It is still an open question whether bedrest and antibiotic prophylaxis by themselves or an additional administration of ribavirin and corticosteroids can improve the outcome.
Conclusion:
SARS is a new and highly contagious lung disease. It is crucial to be able to recognize the clinical appearance and the diagnostic features of this disease at an early stage, in order to prevent a further dissemination of the disease.
Insights
Severe Acute Respiratory Syndrome (SARS) is a new, contagious lung disease. Early recognition of clinical and diagnostic features is crucial to prevent its spread, as seen in early German cases.
Area of Science:
- Infectious Diseases
- Pulmonology
- Virology
Background:
- A novel infectious disease, Severe Acute Respiratory Syndrome (SARS), emerged in February 2003, initially with unknown etiology.
- The disease rapidly spread across Southeast Asia and globally through imported cases.
- This report details the initial clinical presentation, diagnostics, and management of SARS based on early cases in Germany.
Observation:
- Two of three analyzed patients presented with SARS, characterized by sudden-onset fever (>5 days), evolving pulmonary consolidations resistant to antibiotics, and cytopenias.
- Leukopenia, lymphopenia, and thrombocytopenia were noted, with later-stage pulmonary dysfunction.
- Close contacts did not invariably develop severe disease, suggesting variable susceptibility.
Findings:
- A coronavirus was identified in respiratory samples during fever and persisted longer in feces.
- Radiological findings included rapidly changing consolidations on chest X-ray.
- Laboratory results showed leukopenia, lymphopenia, and thrombocytopenia.
Implications:
- Early identification of SARS clinical and diagnostic markers is vital for disease containment.
- The effectiveness of treatments like ribavirin and corticosteroids remains under investigation.
- Understanding transmission dynamics and risk factors is essential for public health strategies.
More Related Videos
03:53Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
Published on: November 10, 2023
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Coronavirus
Respiratory Syncytial Virus Disease
Acute Coronary Syndrome V: Nursing Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: